University of Cincinnati Physicians Company
Welcome,         Profile    Billing    Logout  
 12 Trials 
9 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gupta, Ajay
REMODEL-1, NCT05147220 / 2020-005899-36: Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting
3
800
Europe, US, RoW
Remibrutinib, LOU064, Teriflunomide
Novartis Pharmaceuticals, Novartis Pharma AG
Relapsing Multiple Sclerosis
04/26
10/30
NCT05706454: Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia

Recruiting
2/3
324
RoW
Ramatroban, BAYu3405, IUPAC Name: 3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid, Placebo
KARE Biosciences, JSS Medical Research Inc., Biomedical Advanced Research and Development Authority, Open Philanthropy, Charak Laboratories India Pvt. Ltd, Charak Foundation, BioLink Life Sciences, Inc.
COVID-19 Pneumonia, COVID-19 Respiratory Infection
07/24
05/26
NCT05798520: A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

Recruiting
2
275
Europe, US, RoW
BIIB091, DRF, Placebo
Biogen
Relapsing Forms of Multiple Sclerosis
07/25
11/26
BA3011-001, NCT03425279: CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients with Sarcoma

Active, not recruiting
1/2
300
US, RoW
CAB-AXL-ADC, PD-1 inhibitor
BioAtla, Inc.
Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma
01/25
01/25
CA209-9WW, NCT03628209: Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma

Active, not recruiting
1/2
21
US
Nivolumab, Opdivo®, Azacitidine, Vidaza®, Post Treatment Surgery, Standard of Care, Resection of disease
H. Lee Moffitt Cancer Center and Research Institute, Bristol-Myers Squibb
Osteosarcoma, Osteosarcoma in Children, Osteosarcoma Recurrent, Sarcoma
12/24
12/25
MASTER-2, NCT03933202: A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS

Active, not recruiting
N/A
295
US
Cladribine Tablets
EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany
Multiple Sclerosis
05/25
05/25
Roy-Chaudhury, Prabir
EFFEKTOR, NCT06059664: The EFfect of FinErenone in Kidney TransplantiOn Recipients: The Study

Recruiting
2
150
US
Finerenone Oral Tablet, Kerendia, Placebo, Sugar pill
University of North Carolina, Chapel Hill, Bayer
Kidney Transplant; Complications
02/25
05/26
NCT05105503: Dialysis Access Monitoring Using a Digital Stethoscope-Based Deep Learning System

Recruiting
N/A
50
US
Eko CORE Digital Stethoscope
Eko Devices, Inc., University of North Carolina, Chapel Hill
Dialysis Access Malfunction, Dialysis; Complications
12/24
02/25
WAVE, NCT04540302: The Merit WRAPSODY AV Access Efficacy Study

Active, not recruiting
N/A
357
Europe, Canada, US, RoW
Merit WRAPSODY Endovascular Stent Graft, PTA
Merit Medical Systems, Inc.
Venous Stenosis, Venous Occlusion
02/24
01/26
Pflum, Amy
No trials found
Thomas, M
No trials found
Huddock, Kristen
No trials found
Studer, Autumn
No trials found

Download Options